TVARDI THERAPEUTICS INC

Historical 13F Holders

Symbol
TVRD
CUSIP
140755307
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 140755307 since 12/18/2024, largest first.

Filer % of Class Filed
Slate Path Capital LP 13G
7.5% 8/14/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Ronald A. DePinho 13G/A 4.5% 2/17/2026
Event 12/31/2025
Vifor (International) Ltd 13D/A
2.2% 4/16/2025
Event 4/15/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 5 14.2 k $17.7 k
2026 Q2 57 2.23 M $4.24 M
2026 Q1 68 2.70 M $8.60 M
2025 Q4 66 2.83 M $12.1 M
2025 Q3 71 2.61 M $101 M
2025 Q2 50 1.92 M $44.4 M
2023 Q3 1 77.0 $129.00
2023 Q2 1 77.0 $218.00
2023 Q1 1 77.0 $378.00
2022 Q4 1 77.0 $827.00
2022 Q3 1 77.0 $721.00
2022 Q2 1 77.0 $703.00
2022 Q1 1 77.0 $936.00
2021 Q4 1 77.0 $938.00
2021 Q3 1 77.0 $1.19 k
2021 Q2 1 77.0 $1.10 k
2021 Q1 1 77.0 $1.67 k
2020 Q4 1 77.0 $1.17 k
2020 Q3 1 77.0 $980.00
2020 Q2 1 77.0 $1.32 k